Year-old European startup Maisa named alongside Google and Amazon in elite list of leading AI agent vendors in top global US research reports by Gartner
'We are delighted to be the first Spanish company included by Gartner in its reports and one of only two European companies in the category of AI agents. 'We are especially pleased to be listed alongside global tech titans such as Google and Amazon."
Share
Inclusion in Gartner's 2025 Hype Cycle for AI and Hype Cycle for the Future of Work marks the first time a Spanish startup has been mentioned in these influential reports.
The company, which is barely a year old and made its first raise of $5m+ from leading US investors last year, now finds itself named alongside global giants Amazon Web Services, Google, Salesforce and LangChain.
The Gartner Hype Cycle for AI Agents provides an overview of emerging technologies in AI, helping organizations navigate the evolving landscape of autonomous software agents.
The Hype Cycle for the Future of Work provides CIOs with a crucial human-first lens on the transformative AI advancements and disciplines required to ensure success at scale.
Maisa is one of two European businesses included in its field in the prestigious report. Its technology allows businesses to use agentic AI to create 'digital workers' who can undertake complex process automation tasks such as regulatory compliance, supply chain control and financial management. It has global clients in banking, automotive and energy.
Maisa is unique in the field because its technology is hallucination-resistant. Its workings are traceable and there is a fully auditable trail - what Maisa calls its 'Chain of Work' - meaning businesses can confidently deploy it in critical functions, knowing they can pinpoint exactly how the AI is functioning.
Maisa's CEO and cofounder David Villalón:
'We are delighted to be the first Spanish company included by Gartner in its reports and one of only two European companies in the category of AI agents.
'We are especially pleased to be listed alongside global tech titans such as Google and Amazon.
'Our vision and achievements in empowering companies with autonomous, trustworthy AI agents drive real business value and set new standards for intelligent automation.'
The Gartner analysis highlights AI agents as rapidly maturing technology with a rare 'high benefit' rating, but points out that there is only a 5% - 20% market penetration to date, implying huge market growth potential.
AI agents - defined as autonomous or semi-autonomous software entities capable of perceiving, deciding and acting to achieve goals - are set to revolutionise industries by automating complex tasks, enhancing decision-making and enabling new levels of workflow integration.
About Maisa: A Rising Star in Agentic AI
Its platform allows enterprises to create and manage AI-powered digital workers capable of automating complex, knowledge-intensive business processes with full transparency, traceability and reliability. It is simple to operate, fast to work and trustworthy.
Maisa is enabled by a method the company calls 'HALP' (human-augmented LLM processing), which is a fast, no code and enterprise ready way to train digital workers.
Instead of relying on massive datasets or manual programming, HALP enables digital workers to learn directly from real work inside organisations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
REUTERS NEXT-Google AI spending primarily on technical infrastructure
SINGAPORE (Reuters) -Google's AI investments are primarily in technical infrastructure, Google APAC head of AI and emerging tech policy Eunice Huang said on Wednesday. "As our CEO has said, in these early days of a very transformative technology, the risks of under investing are dramatically higher than the risks of over investing," Huang said, during a panel discussion at the Reuters NEXT Asia summit in Singapore. In April, Alphabet, Google's parent company, said it was still committed to spending some $75 billion this year to build out data centre capacity despite turmoil over U.S. tariffs and sought to reassure investors that its AI plans were yielding good returns. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
CNBC
an hour ago
- CNBC
39-year-old pays $460 in rent for a luxury condo in Chiang Mai, Thailand–take a look inside
When Shao Chun Chen was laid off from his dream job at Google in early 2024, he was forced to take a break and rethink how he wanted his life to look like. Suddenly, he was no longer obligated to stay in his home country of Singapore, where he had built his entire career. "When the layoff happened, I was [reflecting], you know, feeling sorry for myself," the 39-year-old told CNBC Make It. "Then I asked myself: 'Hey, let's flip it around. How can this be a positive thing?" "I wanted to try something different, and I've always enjoyed Thailand," said Chen. He was familiar with the country as his wife was native to Thailand and they had visited it previously. He was drawn to the diverse environments that it offered, from bustling cities to serene beaches and mountains. In addition, he liked how the Asian country had visas and policies that were transparent and friendly to foreigners. Ultimately, Chen said that his layoff allowed him to get out of his comfort zone and experiment with building out his dream life, and as part of this lifestyle re-design, he and his wife moved to Chiang Mai in November 2024. Today, the two reside in a 600-square-foot one-bedroom luxury condo which costs 15,000 Thai baht (about USD $460) a month. The condo came fully furnished, and he pays about $20 a month for utilities, and about $15 a month on WiFi. Chen said he is currently paying for his unit on a month-by-month basis, so his rent would be cheaper if he commits to a longer lease. Previously, his 500-square-foot condo in Singapore cost about $2,500 a month — more than five times the amount he is paying currently in Thailand. His current condo offers amenities such as a gym, a small pilates studio, a co-working space, multiple swimming pools and a water slide. Since getting laid off from his corporate job, Chen works for himself by creating educational content on YouTube and from his coaching business, through which he says he can charge $500 an hour, depending on the client. He has also made money by teaching as an adjunct lecturer at the National University of Singapore, which required him to supercommute between Singapore and Thailand once a week. However, he is now taking a break from this gig, he said. Additionally, Chen has built a seven-figure portfolio over the course of about a decade, according to documents viewed by CNBC Make It, which has afforded him financial independence. Chen noted that life in Thailand is much slower and "zero stress", unlike how mentally taxing it was in Singapore, he said. This has allowed him to cut down on expenses. "When I was in Singapore ... [my job] paid very well, but the lifestyle was very hectic. I was working like 12 to 14 hours a day," he said. Due to the high level of stress he experienced, Chen would cope by spending money on things like therapy, spa visits and drinking on weekends. "The funny thing is that now that I'm here, these things are way more affordable, but I don't even desire [them]," he said. "My head space is completely different." Today, on top of using the gym in his condo, Chen said he occasionally pays for massages, which cost about $15 an hour. "I find that I actually save more money, even though I don't work as much," said Chen. Though he is very happy living in Thailand, he would consider moving back to Singapore if the right opportunity opened up, he said. For now, he is living presently and enjoying the life that Thailand has to offer. "The previous version of myself ... I valued everything on efficiency and ROI," said Chen. "But then here, people don't think that way. They may not have as much as a safety net ... but they seem to enjoy their day to day, and they actually have time to sit down and enjoy their coffee and have time to read a book." "These are some of the simple pleasures that I now am able to afford, which doesn't actually cost a lot," he said.
Gizmodo
2 hours ago
- Gizmodo
An AI That Promises to 'Solve All Diseases' Is About to Test Its First Human Drugs
Deep inside Alphabet, the parent company of Google, a secretive lab is working on a promise so audacious it sounds like science fiction: to 'solve all diseases.' The company, Isomorphic Labs, is now preparing to start its first human clinical trials for cancer drugs designed entirely by artificial intelligence. In a recent interview with Fortune, Colin Murdoch, President of Isomorphic Labs and Chief Business Officer of Google DeepMind, confirmed the company is on the verge of this monumental step. For anyone who has watched a loved one battle a devastating illness, the hope this offers is immense. But for a public increasingly wary of AI's power, it raises a chilling question: can we really trust a 'black box' algorithm with our lives? Isomorphic Labs was born from DeepMind's celebrated AlphaFold breakthrough, the AI system that stunned scientists by predicting the complex 3D shapes of proteins. To understand why this is a big deal, you need to know how drugs are traditionally made. For decades, it's been a slow, brutal process of trial and error. Scientists spend an average of 10 to 15 years and over a billion dollars to bring a single new drug to market, with most candidates failing along the way. Isomorphic Labs uses its AI, AlphaFold 3, to radically accelerate this. The AI can predict the complex 3D structures of proteins in the human body with stunning accuracy, allowing scientists to digitally design new drug molecules that are perfectly shaped to fight a specific disease, all before ever entering a physical lab The company has already signed multi-billion dollar deals with pharmaceutical giants Novartis and Eli Lilly, and just raised $600 million in new funding to move its own drug candidates—starting with oncology—into human trials. The promise is a medical utopia. 'This funding will further turbocharge the development of our next-generation AI drug design engine, help us advance our own programs into clinical development, and is a significant step forward towards our mission of one day solving all disease with the help of AI,' CEO Sir Demi Hassabis, who won the 2024 Nobel Laureate in Chemistry for his pioneering work on AlphaFold 2, said back in March. But when Big Tech starts designing medicine, who owns your cure? This is where deep-seated fears about AI's role in our lives come into focus. The biggest concern is the 'black box' problem: we know the AI gives an answer, but we don't always know how. This raises critical questions: When contacted by Gizmodo, a spokesperson for Isomorphic Labs said the company 'don't have anything more to share.' AI could revolutionize medicine. But if left unchecked, it could also replicate the worst parts of the tech industry: opacity, monopoly, and profit over access. Isomorphic Labs is pushing humanity toward a monumental turning point. If they succeed, they could alleviate more suffering than any other invention in history. But to do so, they first have to convince a skeptical public that the promise is worth the unprecedented risk.
